← Back to Search
Calretinin Expression In Human Normal And Neoplastic Tissues: A Tissue Microarray Analysis On 5233 Tissue Samples.
A. Lugli, Yvonne Forster, P. Haas, A. Nocito, C. Bucher, H. Bissig, M. Mirlacher, M. Storz, M. Mihatsch, G. Sauter
Published 2003 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Calretinin is a calcium-binding protein expressed in different normal and neoplastic tissues. Early studies suggested that calretinin is a useful marker to differentiate adenocarcinomas from malignant mesotheliomas of the lung, but subsequent work has shown that calretinin can be expressed in several other tumor types. To systematically investigate the epidemiology of calretinin expression in normal and neoplastic tissues, we used tissue microarrays (TMAs) to analyze the immunohistochemically detectable expression of calretinin in 5233 tissue samples from 128 different tumor categories and 76 different normal tissue types. At least 1 case with weak expression could be found in 74 of 128 (58%) different tumor types and 46 entities (36%) had at least 1 tumor with strong positivity. In normal tissues, a particularly strong expression was found in Leydig cells of the testis, neurons of the brain, theca-lutein and theca interna cells of the ovary, and mesothelium. In tumors, strong calretinin expression was most frequently found in malignant mesotheliomas (6 of 7), Leydig cell tumors of the testis (5 of 5), adenomas of adrenal gland (5 of 9), and adenomatoid tumors (4 of 9). In summary, calretinin is frequently expressed in many different tumor types. Metastases of various different origins must be included in the differential diagnosis of calretinin-positive pleura tumors.
This paper references
Calretinin and other CaBPs in the nervous system.
J. Rogers (1990)
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
J. Torhorst (2001)
Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies
L. Bubendorf (2001)
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
H. Moch (1999)
Parvalbumin and calretinin in the avian thymus
E. Király (2004)
Mucinous Cystic Tumors of the Pancreas
T. Hara (2002)
Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma.
Y. Matsuno (1998)
[Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies].
M. Chenard-Neu (1998)
Calcium-binding proteins: selective markers of nerve cells
C. Andressen (2004)
Calretinin is expressed in the Leydig cells of rat testis.
K. Strauss (1994)
Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
M. Barberis (1997)
Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.
G. Zamboni (1999)
R. Kretsinger (1976)
Calretinin immunoreactivity in adrenal glands of developing, adult and ageing Sprague-Dawley rats
M. Afework (1995)
Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations.
L. Terracciano (2000)
Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies.
F. Roberts (2001)
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
A. Nocito (2001)
The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
V. Gotzos (1996)
Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis
R. Carella (2001)
HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma
Selective immunocytochemical localisation of calretinin in the human ovary
S. Bertschy (1997)
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
Structure of the human brain calcium-binding protein calretinin and its expression in bacteria.
M. Parmentier (1991)
Tissue microarrays for gene amplification surveys in many different tumor types.
P. Schraml (1999)
Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues.
V. Gotzos (1999)
Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors
Q. Cao (2001)
The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology.
H. Nagel (1998)
Tissue microarrays for high-throughput molecular profiling of tumor specimens
J. Kononen (1998)
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
R. Simon (2001)
An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.
U. Brockstedt (2000)
Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura
P. Cury (2000)
Calretinin is transiently expressed in tendon fibroblasts of the paravertebral region of the chick embryo.
V. Gangji (1997)
Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms
R. Attanoos (2000)
Calretinin expression in ameloblastomas
M. Altini (2000)
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells.
R. Simon (2001)
This paper is referenced by
S. Lau (2005)
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
N. Ordóñez (2013)
Calretinin as a Diagnostic Adjunct for Ameloblastoma
C. Anandani (2014)
Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis
M. Alaeddini (2008)
Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis
P. Mhawech-Fauceglia (2006)
Expression of Mesothelial Marker Calretinin in Breast Cancer
Kalathingal Kamarunisha Aboobacker (2019)
Inhibin-α, E-cadherin, calretinin and Ki-67 antigen in the immunohistochemical evaluation of canine and human testicular neoplasms.
Rafał Ciaputa (2014)
Identification of the Most Sensitive and Robust Immunohistochemical Markers in Different Categories of Ovarian Sex Cord-stromal Tumors
C. Zhao (2009)
Calretinin expression in tumors of adipose tissue.
J. Cates (2006)
Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers
F. Person (2017)
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
Large cell calcifying Sertoli cell tumor of the testis: Comparative immunohistochemical study with Leydig cell tumor
Katsuaki Sato (2005)
Molecular Biomarkers and Network Analyses of Neuron-type Connectivity Reveal Cloaked Insights into Hippocampal Function
C. L. Rees (2016)
Tumors of the endocrine system
P. Chu (2014)
Comparative Analysis of Alternative and Traditional Immunohistochemical Markers for the Distinction of Ovarian Sertoli Cell Tumor From Endometrioid Tumors and Carcinoid Tumor: A Study of 160 Cases
C. Zhao (2007)
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
Kaire Ojasalu (2020)
Immunohistochemistry of pulmonary and pleural neoplasia.
M. Beasley (2008)
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
V. Ascoli (2016)
Best Practices Recommendations in the Application of Immunohistochemistry in Testicular Tumors: Report From the International Society of Urological Pathology Consensus Conference
T. Ulbright (2014)
Interleukin‐2 Production by Cultured Human Granulosa Cells
R. Orvieto (2015)
Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.
T. Fukazawa (2008)
An Immunohistochemical Analysis of Ovarian Small Cell Carcinoma of Hypercalcemic Type
W. G. McCluggage (2004)
Quantitative Analysis of a Promising Cancer Biomarker, Calretinin, by a Biosensing System Based on Simple and Effective Immobilization Process
Engin Asav (2016)
[Adenomatoid tumor of the testes--a rare entity. Clinical, diagnostic and therapeutic aspects].
M. Lehsnau (2006)
Pleomorphic carcinoma of the lung expressing podoplanin and calretinin
H. Kenmotsu (2008)
Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry
Fanny Burel-Vandenbos (2010)
Surface Epithelial Tumors of the Ovary
J. Seidman (2011)
Identification of Signet Ring Cell Change in Colonic Subserosa in the Setting of Clostridium difficile Colitis
O. Khan (2017)
The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin
M. Mahalingam (2010)
Calretinin expression in odontogenic cysts and odontogenic tumors and the possible role of calretinin in pathogenesis of ameloblastoma
Amrutha Rudraraju (2019)
The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis.
R. Emerson (2005)
Prognostic significance of the wnt signalling pathway molecules APC, β‐catenin and E‐cadherin in colorectal cancer—a tissue microarray‐based analysis
A. Lugli (2007)See more